Lucid Diagnostics Stock Price on May 19, 2024
| LUCD Stock | USD 0.89 0.02 2.20% |
If you're considering investing in Lucid Stock, it is important to understand the factors that can impact its price. As of today, the current price of Lucid Diagnostics stands at 0.89, as last reported on the 2nd of June, with the highest price reaching 0.93 and the lowest price hitting 0.89 during the day. Lucid Diagnostics has Sharpe Ratio of -0.0715, which conveys that the firm had a -0.0715% return per unit of risk over the last 3 months. Lucid Diagnostics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lucid Diagnostics' Standard Deviation of 5.05, risk adjusted performance of (0.04), and Mean Deviation of 3.12 to check out the risk estimate we provide.
At present, Lucid Diagnostics' Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 7 M, whereas Total Stockholder Equity is projected to grow to (2.2 M). . The current year's Price Earnings To Growth Ratio is expected to grow to 0.06, whereas Price To Sales Ratio is forecasted to decline to 23.04. Lucid Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Lucid |
Sharpe Ratio = -0.0715
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LUCD |
Estimated Market Risk
| 5.1 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.36 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lucid Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lucid Diagnostics by adding Lucid Diagnostics to a well-diversified portfolio.
Price Book 2.159 | Enterprise Value Ebitda (1.09) | Price Sales 16.075 | Shares Float 14.8 M | Wall Street Target Price 3.83 |
Related Headline
Clearpoint Neuro Headline on 17th of May 2024
Acquisition by Fallon Lynnette C of 21093 shares of Clearpoi... by Fallon Lynnette C
Filed transaction by Clearpoint Neuro Director. Grant, award or other acquisition pursuant to Rule 16b-3
Lucid Diagnostics Valuation on May 19, 2024
It is possible to determine the worth of Lucid Diagnostics on a given historical date. On May 19, 2024 Lucid was worth 0.89 at the beginning of the trading date compared to the closed value of 0.91. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lucid Diagnostics stock. Still, in general, we apply an absolute valuation method to find Lucid Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lucid Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lucid Diagnostics' related companies.
| Open | High | Low | Close | Volume | |
| 0.89 | 0.92 | 0.88 | 0.89 | 90,799 | |
05/17/2024 | 0.89 | 0.93 | 0.88 | 0.91 | 85,652 |
| 0.93 | 0.94 | 0.90 | 0.93 | 158,379 |
| Backtest Lucid Diagnostics | | | Lucid Diagnostics History | | | Lucid Diagnostics Valuation | Previous | Next |
Lucid Diagnostics Trading Date Momentum on May 19, 2024
| On May 20 2024 Lucid Diagnostics was traded for 0.93 at the closing time. The top price for the day was 0.94 and the lowest listed price was 0.90 . The trading volume for the day was 158.4 K. The trading history from May 20, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 2.20% . The trading delta at closing time against the current closing price is 3.30% . |
Lucid Diagnostics Fundamentals Correlations and Trends
By evaluating Lucid Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lucid Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lucid financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lucid Diagnostics Stock history
Lucid Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lucid is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lucid Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lucid Diagnostics stock prices may prove useful in developing a viable investing in Lucid Diagnostics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 41.8 M | 41.1 M | |
| Net Loss | -50.6 M | -48 M |
Lucid Diagnostics Stock Technical Analysis
Lucid Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lucid Diagnostics Period Price Range
Low | May 17, 2024
| High |
0.89 | 0.91 |
Lucid Diagnostics June 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Lucid Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lucid Diagnostics shares will generate the highest return on investment. By undertsting and applying Lucid Diagnostics stock market strength indicators, traders can identify Lucid Diagnostics entry and exit signals to maximize returns
Lucid Diagnostics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lucid Diagnostics' price direction in advance. Along with the technical and fundamental analysis of Lucid Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lucid to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | 1.07 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lucid Diagnostics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.Note that the Lucid Diagnostics information on this page should be used as a complementary analysis to other Lucid Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Lucid Stock analysis
When running Lucid Diagnostics' price analysis, check to measure Lucid Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lucid Diagnostics is operating at the current time. Most of Lucid Diagnostics' value examination focuses on studying past and present price action to predict the probability of Lucid Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lucid Diagnostics' price. Additionally, you may evaluate how the addition of Lucid Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Lucid Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lucid Diagnostics. If investors know Lucid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lucid Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.26) | Revenue Per Share 0.07 | Quarterly Revenue Growth 1.244 | Return On Assets (0.69) | Return On Equity (2.56) |
The market value of Lucid Diagnostics is measured differently than its book value, which is the value of Lucid that is recorded on the company's balance sheet. Investors also form their own opinion of Lucid Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Lucid Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lucid Diagnostics' market value can be influenced by many factors that don't directly affect Lucid Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lucid Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lucid Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lucid Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.